CARDIFF ONCOLOGY, INC. Proceeds from Common Stock Issued
CARDIFF ONCOLOGY, INC. (CRDF) reported Proceeds from Common Stock Issued of $212.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. proceeds from issuance of common stock for the quarter ending 2024-12-31 was $44.17M.
- CARDIFF ONCOLOGY, INC. proceeds from issuance of common stock for the quarter ending 2024-09-30 was $7.40M.
- CARDIFF ONCOLOGY, INC. proceeds from issuance of common stock for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- CARDIFF ONCOLOGY, INC. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $0.00.
- CARDIFF ONCOLOGY, INC. proceeds from issuance of common stock for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- CARDIFF ONCOLOGY, INC. proceeds from issuance of common stock for fiscal 2024 was $53.41M.
- CARDIFF ONCOLOGY, INC. proceeds from issuance of common stock for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- CARDIFF ONCOLOGY, INC. proceeds from issuance of common stock for fiscal 2021 was $34.19M, a 69.56% decline from fiscal 2020.
| Period end | Proceeds from Issuance of Common Stock 1 month | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 3 month as first filed | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 6 month as first filed | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month | Proceeds from Issuance of Common Stock 12 month as first filed | Proceeds from Issuance of Common Stock 152 month | Proceeds from Issuance of Common Stock 155 month | Proceeds from Issuance of Common Stock 158 month | Proceeds from Issuance of Common Stock 161 month | Proceeds from Issuance of Common Stock 164 month | Proceeds from Issuance of Common Stock 167 month | Proceeds from Issuance of Common Stock 170 month | Proceeds from Issuance of Common Stock 173 month | Proceeds from Issuance of Common Stock 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $212.00K 10-Q · filed 2026-08-11 | |||||||||||||||||
| 2025-12-31 | $0.00 10-K · filed 2026-02-24 | |||||||||||||||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-11 | |||||||||||||||||
| 2024-12-31 | $44.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $51.58M derived: sum of 2 quarters · filed 2026-02-24 | $53.41M 10-K · filed 2026-02-24 | |||||||||||||||
| 2024-09-30 | $7.40M 10-Q · filed 2024-11-07 | $9.23M 10-Q · filed 2025-11-06 | ||||||||||||||||
| 2024-06-30 | $1.80M 10-Q · filed 2024-08-08 | $1.80M 10-Q · filed 2025-07-29 | ||||||||||||||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | |||||||||||||||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $0.00 derived: sum of 2 quarters · filed 2023-03-02 | $0.00 10-K · filed 2023-03-02 | |||||||||||||||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||||||||||||||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-04 | |||||||||||||||||
| 2021-12-31 | $14.96M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $14.96M derived: sum of 2 quarters · filed 2023-03-02 | $34.19M derived: sum of 3 quarters · filed 2023-03-02 | $34.19M 10-K · filed 2023-03-02 | ||||||||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $19.23M derived: sum of 2 quarters · filed 2022-11-03 | $19.23M 10-Q · filed 2022-11-03 | $113.25M derived: sum of 4 quarters · filed 2022-11-03 | ||||||||||||||
| 2021-06-30 | $19.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $19.23M 10-Q · filed 2022-08-04 | $113.25M derived: sum of 3 quarters · filed 2022-08-04 | $112.72M derived: sum of 4 quarters · filed 2022-08-04 | ||||||||||||||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-06 | $94.02M derived: sum of 2 quarters · filed 2022-02-24 | $93.50M derived: sum of 3 quarters · filed 2022-02-24 | $111.30M derived: sum of 4 quarters · filed 2022-02-24 | ||||||||||||||
| 2020-12-31 | $94.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $93.50M derived: sum of 2 quarters · filed 2022-02-24 | $111.30M derived: sum of 3 quarters · filed 2022-02-24 | $112.30M 10-K · filed 2022-02-24 | $112.30M 10-K · filed 2021-02-25 | |||||||||||||
| 2020-09-30 | -$523.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $17.28M derived: sum of 2 quarters · filed 2021-11-04 | $18.28M 10-Q · filed 2021-11-04 | $18.28M 10-Q · filed 2020-11-05 | $22.71M derived: sum of 4 quarters · filed 2021-11-04 | |||||||||||||
| 2020-06-30 | $17.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $18.80M 10-Q · filed 2021-08-05 | $18.80M 10-Q · filed 2020-08-11 | $23.23M derived: sum of 3 quarters · filed 2021-08-05 | $24.72M derived: sum of 4 quarters · filed 2021-08-05 | |||||||||||||
| 2020-03-31 | $1.00M 10-Q · filed 2021-05-06 | $1.00M 10-Q · filed 2020-05-07 | $5.43M derived: sum of 2 quarters · filed 2021-05-06 | $6.92M derived: sum of 3 quarters · filed 2021-05-06 | $9.82M derived: sum of 4 quarters · filed 2021-05-06 | |||||||||||||
| 2019-12-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $5.92M derived: sum of 2 quarters · filed 2021-02-25 | $8.82M derived: sum of 3 quarters · filed 2021-02-25 | $8.82M 10-K · filed 2021-02-25 | ||||||||||||||
| 2019-09-30 | $1.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $4.39M derived: sum of 2 quarters · filed 2020-11-05 | $4.39M 10-Q · filed 2020-11-05 | $4.39M derived: sum of 4 quarters · filed 2020-11-05 | ||||||||||||||
| 2019-06-30 | $2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | $2.90M 10-Q · filed 2020-08-11 | $2.90M derived: sum of 3 quarters · filed 2020-08-11 | $2.90M derived: sum of 4 quarters · filed 2020-08-11 | ||||||||||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2020-05-07 | $0.00 derived: sum of 3 quarters · filed 2020-05-07 | |||||||||||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $0.00 derived: sum of 2 quarters · filed 2020-02-27 | $11.78M 10-K · filed 2020-02-27 | $13.12M 10-K · filed 2019-03-06 | ||||||||||||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $11.78M 10-Q · filed 2019-11-07 | ||||||||||||||||
| 2018-06-30 | $11.78M 10-Q · filed 2019-08-08 | |||||||||||||||||
| 2017-12-31 | $5.09M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $11.62M derived: sum of 2 quarters · filed 2019-03-06 | $11.73M 10-K · filed 2019-03-06 | |||||||||||||||
| 2017-09-30 | $6.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $6.63M 10-Q · filed 2018-11-07 | ||||||||||||||||
| 2017-06-30 | $106.79K 10-Q · filed 2018-08-03 | |||||||||||||||||
| 2016-12-31 | $70.94K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $2.36M derived: sum of 2 quarters · filed 2018-02-26 | $2.36M derived: sum of 3 quarters · filed 2018-02-26 | $2.36M 10-K · filed 2018-02-26 | $2.29M 10-K · filed 2017-03-15 | |||||||||||||
| 2016-09-30 | $2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $2.29M derived: sum of 2 quarters · filed 2017-11-09 | $2.29M 10-Q · filed 2017-11-09 | $2.29M derived: sum of 4 quarters · filed 2017-11-09 | ||||||||||||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | $1.00 derived: sum of 3 quarters · filed 2017-08-09 | $37.40M derived: sum of 4 quarters · filed 2017-08-09 | ||||||||||||||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-10 | $1.00 derived: sum of 2 quarters · filed 2017-03-15 | $37.40M derived: sum of 3 quarters · filed 2017-03-15 | $39.77M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||||||
| 2015-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $37.40M derived: sum of 2 quarters · filed 2017-03-15 | $39.77M derived: sum of 3 quarters · filed 2017-03-15 | $61.22M 10-K · filed 2017-03-15 | ||||||||||||||
| 2015-09-30 | $37.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $39.77M derived: sum of 2 quarters · filed 2016-11-09 | $61.22M 10-Q · filed 2016-11-09 | $61.22M derived: sum of 4 quarters · filed 2017-03-15 | ||||||||||||||
| 2015-06-30 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $23.82M 10-Q · filed 2016-08-04 | $23.82M derived: sum of 3 quarters · filed 2017-03-15 | |||||||||||||||
| 2015-03-31 | $21.45M 10-Q · filed 2016-05-10 | $21.45M derived: sum of 2 quarters · filed 2017-03-15 | ||||||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | ||||||||||||||||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | |||||||||||||||||
| 2014-03-31 | $51.59M 10-Q · filed 2014-05-12 | |||||||||||||||||
| 2013-12-31 | -$67.74K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $18.83M 10-K · filed 2016-03-10 | $51.59M 10-K · filed 2014-03-17 | |||||||||||||||
| 2013-09-30 | $18.90M 10-Q · filed 2014-11-06 | $51.65M 10-Q · filed 2013-11-14 | ||||||||||||||||
| 2013-06-30 | $32.76M 10-Q · filed 2013-08-14 | |||||||||||||||||
| 2013-03-31 | $32.76M 10-Q · filed 2013-05-14 | |||||||||||||||||
| 2012-12-31 | $4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $4.38M derived: sum of 2 quarters · filed 2015-03-12 | $14.43M derived: sum of 3 quarters · filed 2015-03-12 | $15.32M 10-K · filed 2015-03-12 | $32.76M 10-K · filed 2013-04-01 | |||||||||||||
| 2012-09-30 | -$490.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $10.06M derived: sum of 2 quarters · filed 2013-11-14 | $10.95M 10-Q · filed 2013-11-14 | $12.01M derived: sum of 4 quarters · filed 2014-03-17 | $28.38M 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $10.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $10.95M 10-Q · filed 2013-08-14 | $12.01M derived: sum of 3 quarters · filed 2014-03-17 | $12.55M derived: sum of 4 quarters · filed 2014-03-17 | $28.38M 10-Q · filed 2012-08-14 | |||||||||||||
| 2012-03-31 | $889.50K 10-Q · filed 2013-05-14 | $1.95M derived: sum of 2 quarters · filed 2014-03-17 | $2.49M derived: sum of 3 quarters · filed 2014-03-17 | $2.86M derived: sum of 4 quarters · filed 2014-03-17 | $18.32M 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $1.60M derived: sum of 2 quarters · filed 2014-03-17 | $1.97M derived: sum of 3 quarters · filed 2014-03-17 | $2.57M 10-K · filed 2014-03-17 | ||||||||||||||
| 2011-09-30 | $535.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $910.00K derived: sum of 2 quarters · filed 2012-11-14 | $1.51M 10-Q · filed 2012-11-14 | |||||||||||||||
| 2011-06-30 | $375.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $975.00K 10-Q · filed 2012-08-14 | ||||||||||||||||
| 2011-03-31 | $600.00K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |